Patent · US Active

cMET inhibitors

US8178534B2 · kind B2 · utility

0Cited by
1References
53Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2009
Grant dateMay 15, 2012
Priority date
Expiry dateApr 23, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the following formula are provided for use with cMET:wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.